Evidence map›Paper›PMID 39958486›Full record

ArticleMacromolecules2025

Sustainable and Surfactant-Free Synthesis of Negatively Charged Acrylamide Nanogels for Biomedical Applications.

Davide Mazzali, Gabriela Rath, Alexander Röntgen, Vaidehi Roy Chowdhury, Michele Vendruscolo, Marina Resmini

Abstract read
In one paragraph

Article in Macromolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Investigating the Effects of Nanogels in Promoting Protein Crystallization.International journal of molecular sciences · 2026
    Article
  2. Self-Surfactant Poly-3hydroxybutyrate-ACS applied bio materials · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Davide MazzaliDepartment of Chemistry, SPCS, Queen Mary University of London, London E1 4NS, U.K.
Gabriela RathDepartment of Chemistry, SPCS, Queen Mary University of London, London E1 4NS, U.K.
Alexander RöntgenCentre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.
Vaidehi Roy ChowdhuryCentre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.
Michele VendruscoloCentre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.ORCID https://orcid.org/0000-0002-3616-1610
Marina ResminiDepartment of Chemistry, SPCS, Queen Mary University of London, London E1 4NS, U.K.ORCID https://orcid.org/0000-0001-8109-5352

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanogels offer unique advantages, like high surface-to-volume ratio, scalable synthetic methods, and easily tailored formulations, that allow us to control size and introduce stimuli-responsive properties. Their potential for drug delivery is significant due to their biocompatibility, high drug loading capacity, and controlled and sustained drug release. The development of greener and sustainable processes is essential for large-scale applications. We report the synthesis in water of covalently cross-linked acrylamide-based nanogels, both neutral and negatively charged, with varying amounts of acryloyl-l-proline, using high-dilution radical polymerization, without the need for surfactants. The use of a water-based synthesis resulted in nanogels with high monomer conversions and chemical yields, as well as lower polydispersity and smaller particle sizes for the negatively charged nanogels, leading to a more efficient synthetic methodology, with reduced loss of starting materials, higher potential for scalability, and reduction in costs. The suitability of these nanogels for biomedical applications was supported by cytotoxicity studies showing no significant reduction in viability on a human neuroblastoma cell line.

Identifiers

PMID39958486
PMCPMC11823596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.